(S)-2-(4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)-ethyl]-benzoylamino)-pentanedioicacid diethylester

CAS: 146943-43-3

Ref. 3D-FA151584

Informação sobre produto

• Nome: (S)-2-(4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)-ethyl]-benzoylamino)-pentanedioicacid diethylester
• Sinónimos: N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester, (s)-diethyl-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido) pentanedioate

Descrição

Pemetrexed is a cancer drug that belongs to the group of diacids. It is chemically stable and has been shown to have anticancer activity in mammalian cells. Pemetrexed inhibits the growth of mesothelioma, a type of lung cancer, by binding to DNA and inhibiting DNA synthesis. The process optimization for pemetrexed was done by investigating different salt formulations, such as sodium salts or carboxylates. This drug can be used in combination with other anticancer drugs to treat other types of cancer, such as pleural mesothelioma or heptahydrate. Pemetrexed has been approved for use in Canada as an anticancer agent for the treatment of mesothelioma and lung cancers (e.g., non-small cell lung cancer).

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 483.52 g/mol
• Fórmula: C₂₄H₂₉N₅O₆
• Pureza: Min. 95%